Details of the Drug
General Information of Drug (ID: DM29FTF)
Drug Name |
VU-29
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide; VU 29; 890764-36-0; DPAP; N-(1,3-diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide; CHEMBL411221; 4-nitro-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide; N-(2,5-diphenylpyrazol-3-yl)-4-nitro-benzamide; SCHEMBL1821818; VU29; GTPL6403; KS-00002WSR; DTXSID60469437; MolPort-020-313-399; BCP27694; ZINC13704338; BDBM50187615; AKOS005266482; ES-0027; NCGC00370929-02; AN-16932; B7668; FT-0704727; N-[2,5-di(phenyl)pyrazol-3-yl]-4-nitrobenzamide; VU 29
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||